Kiniksa Pharmaceuticals International, plc Weighted Average Number of Shares Outstanding, Basic from 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to Q3 2025.
  • Kiniksa Pharmaceuticals International, plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 74.7M shares, a 4.17% increase year-over-year.
  • Kiniksa Pharmaceuticals International, plc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 71.4M shares, a 1.95% increase from 2023.
  • Kiniksa Pharmaceuticals International, plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 70.1M shares, a 0.98% increase from 2022.
  • Kiniksa Pharmaceuticals International, plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 69.4M shares, a 1.18% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Kiniksa Pharmaceuticals International, plc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 74.7M +2.99M +4.17% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 73.4M +2.43M +3.43% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-29
Q1 2025 72.6M +2.01M +2.85% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-29
Q4 2024 71.4M +1.37M +1.95% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 71.7M +1.54M +2.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 71M +1.09M +1.55% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-29
Q1 2024 70.6M +881K +1.26% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-29
Q4 2023 70.1M +677K +0.98% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 70.2M +741K +1.07% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 69.9M +628K +0.91% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 69.8M +615K +0.89% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 69.4M +805K +1.18% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 69.4M +782K +1.14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 69.3M +894K +1.31% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 69.1M +867K +1.27% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 68.6M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 68.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 68.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 68.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05

Kiniksa Pharmaceuticals International, plc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 71.4M +1.37M +1.95% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 70.1M +677K +0.98% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 69.4M +805K +1.18% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 68.6M +6.73M +10.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 61.8M +7.79M +14.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 54M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.